Pfizer’s plunging Paxlovid sales impact revenue as COVID fades
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
